124 related articles for article (PubMed ID: 22449346)
1. Novel insights into the relationship between glomerular pathology and progressive kidney disease.
Satirapoj B; Nast CC; Adler SG
Adv Chronic Kidney Dis; 2012 Mar; 19(2):93-100. PubMed ID: 22449346
[TBL] [Abstract][Full Text] [Related]
2. Kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as prognostic markers in idiopathic membranous nephropathy.
Maas RJ; van den Brand JA; Waanders F; Meijer E; Goor van H; Peters HP; Hofstra JM; Wetzels JF
Ann Clin Biochem; 2016 Jan; 53(Pt 1):51-7. PubMed ID: 25762211
[TBL] [Abstract][Full Text] [Related]
3. Tubular biomarkers to assess progression of diabetic nephropathy.
Tramonti G; Kanwar YS
Kidney Int; 2011 May; 79(10):1042-4. PubMed ID: 21527942
[TBL] [Abstract][Full Text] [Related]
4. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.
Nielsen SE; Andersen S; Zdunek D; Hess G; Parving HH; Rossing P
Kidney Int; 2011 May; 79(10):1113-8. PubMed ID: 21270761
[TBL] [Abstract][Full Text] [Related]
5. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
[TBL] [Abstract][Full Text] [Related]
7. Novel biomarkers indicating repair or progression after acute kidney injury.
Kashani K; Kellum JA
Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):21-7. PubMed ID: 25415614
[TBL] [Abstract][Full Text] [Related]
8. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of tubulointerstitial injury by new biomarkers].
Mori K; Mukoyama M; Kasahara M; Nakao K
Nihon Jinzo Gakkai Shi; 2011; 53(4):596-9. PubMed ID: 21688478
[No Abstract] [Full Text] [Related]
10. Complement activation and kidney injury molecule-1-associated proximal tubule injury in severe preeclampsia.
Burwick RM; Easter SR; Dawood HY; Yamamoto HS; Fichorova RN; Feinberg BB
Hypertension; 2014 Oct; 64(4):833-8. PubMed ID: 24958504
[TBL] [Abstract][Full Text] [Related]
11. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
[TBL] [Abstract][Full Text] [Related]
12. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
[TBL] [Abstract][Full Text] [Related]
13. Emerging urinary markers of renal injury in obstructive nephropathy.
Lucarelli G; Mancini V; Galleggiante V; Rutigliano M; Vavallo A; Battaglia M; Ditonno P
Biomed Res Int; 2014; 2014():303298. PubMed ID: 25101270
[TBL] [Abstract][Full Text] [Related]
14. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy.
Ding H; He Y; Li K; Yang J; Li X; Lu R; Gao W
Clin Immunol; 2007 May; 123(2):227-34. PubMed ID: 17360238
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of renal function, which and when?
Wasung ME; Chawla LS; Madero M
Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
[TBL] [Abstract][Full Text] [Related]
16. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
17. The early diagnosis of acute renal graft dysfunction: a challenge we face. The role of novel biomarkers.
Halawa A
Ann Transplant; 2011; 16(1):90-8. PubMed ID: 21436782
[TBL] [Abstract][Full Text] [Related]
18. Are recently reported biomarkers helpful for early and accurate diagnosis of acute kidney injury?
Barrera-Chimal J; Bobadilla NA
Biomarkers; 2012 Aug; 17(5):385-93. PubMed ID: 22515481
[TBL] [Abstract][Full Text] [Related]
19. [Early biomarker for AKI].
Mori K; Mukoyama M; Nakao K
Nihon Jinzo Gakkai Shi; 2010; 52(5):566-71. PubMed ID: 20715588
[No Abstract] [Full Text] [Related]
20. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.
Nielsen SE; Schjoedt KJ; Astrup AS; Tarnow L; Lajer M; Hansen PR; Parving HH; Rossing P
Diabet Med; 2010 Oct; 27(10):1144-50. PubMed ID: 20854382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
